Myasthenia Gravis Clinical Trials in Australia

Living with myasthenia gravis can present many challenges, which is why ongoing research is so important.

Clinical trials play a vital role in improving our understanding of myasthenia gravis and helping to develop new treatments, therapies, and approaches to care.

Myasthenia Alliance Australia is committed to sharing information about clinical trial opportunities that may be relevant to the Australian MG community. While MAA does not conduct or manage these studies, we work to connect people living with myasthenia gravis with trusted research opportunities from recognised institutions, hospitals, and research organisations.

Whether you are interested in participating in a clinical trial, learning more about current research, or simply staying informed about developments in MG treatment, this page provides a central location for information and opportunities currently available in Australia.

Current clinical trial opportunities are listed below and will be updated as new studies become available.

 

Understanding Clinical Trials

Clinical trials are carefully designed research studies that help researchers evaluate new treatments, medications, and approaches to managing myasthenia gravis (MG). They are an essential part of medical research, providing evidence about the safety and effectiveness of potential therapies before they become widely available to patients.

Researchers rely on volunteers to help advance the understanding of MG and improve future treatment options. By participating in clinical trials, individuals contribute to research that may lead to better therapies, improved quality of life, and more effective care for people living with myasthenia gravis now and in the future.

Research coordinator reviewing clinical trial information with a participant considering involvement in a myasthenia gravis research study.

Key Impact Areas

Clinical trials help advance research into myasthenia gravis and may contribute to the development of future treatments, improved care, and a better understanding of the condition.

Here are some of the potential benefits of participating in a clinical trial:

Access to Emerging Treatments
  • Clinical trials may provide access to new therapies before they become widely available.
Support Medical Research
  • Help researchers improve the understanding and treatment of myasthenia gravis.
Contribute to Future Care
  • Your participation may benefit future generations living with MG.
Advance Knowledge
  • Clinical trials help identify safer and more effective treatment options.

Stay Informed About New Clinical Trials

Receive Updates on Clinical Trials and Research

Be part of the movement to raise awareness, support advocacy, and drive research for Myasthenia Gravis. Register for the MAA News Feed and receive updates on events, fundraising opportunities, and ways to contribute.

Please enter your name.
Please enter a valid email address.
Something went wrong. Please check your entries and try again.

CURRENT MYASTHENIA GRAVIS CLINICAL TRIALS

Myasthenia Alliance Australia is committed to helping the Australian MG community stay informed about current clinical trials and research opportunities. The studies listed below may involve emerging treatments, new approaches to care, or research designed to improve our understanding of myasthenia gravis.

Clinical trial opportunities are updated as information becomes available. Click on any study below to learn more about eligibility requirements, locations, and participation details.

Browse the latest clinical trial opportunities below.

Associate Professor Stephen Reddel inviting people with generalised myasthenia gravis in NSW to participate in a clinical trial study.
A message to the Australian MG community and in particular to patients in NSW from Associate Professor Stephen Reddel.
MyClad Study clinical trial banner inviting Australians with myasthenia gravis to participate in MG research